 Idiopathic thrombocytopenic purpura pregnancy randomized trial effect antenatal low dose corticosteroids neonatal platelet count OBJECTIVE efficacy antenatal low dose oral betamethasone neonatal thrombocytopenia and/or bleeding infants mothers idiopathic thrombocytopenic purpura ITP SETTING Hospital department obstetrics gynaecology referral centre PATIENTS pregnancies women results pregnancies non-assessable final analysis betamethasone group non-treatment group criteria ITP INTERVENTIONS treated group mg day day till day mg day till delivery MAIN OUTCOME MEASURES Effects treatment terms maternal platelet counts first trimester neonatal platelet counts birth first week life neonatal bleeding episodes RESULTS significant differences neonatal platelet counts birth infants betamethasone group untreated group severe thrombocytopenia birth first week life /l Seven infants betamethasone group non-treatment group mild thrombocytopenia overall frequency neonatal thrombocytopenia similar betamethasone group untreated group CI true difference significant difference neonatal bleeding episodes CONCLUSIONS Low-dose betamethasone pregnant women ITP thrombocytopenia bleeding newborn infants